Published in PLoS One on June 07, 2013
Focal targeting by human β-defensin 2 disrupts localized virulence factor assembly sites in Enterococcus faecalis. Proc Natl Acad Sci U S A (2013) 0.93
FbsC, a novel fibrinogen-binding protein, promotes Streptococcus agalactiae-host cell interactions. J Biol Chem (2014) 0.84
Group B streptococcal infection and activation of human astrocytes. PLoS One (2015) 0.77
Evaluation of small molecule SecA inhibitors against methicillin-resistant Staphylococcus aureus. Bioorg Med Chem (2015) 0.75
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep (2010) 7.06
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA (2008) 6.13
Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol (2002) 4.82
Sortase-catalysed anchoring of surface proteins to the cell wall of Staphylococcus aureus. Mol Microbiol (2001) 3.39
Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet (2012) 2.98
Assembly and role of pili in group B streptococci. Mol Microbiol (2006) 2.92
Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibiotics. Proc Natl Acad Sci U S A (2006) 2.53
Subcellular sites for bacterial protein export. Mol Microbiol (2004) 2.50
The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon. J Bacteriol (2000) 2.45
Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev (2005) 2.36
Dual role for pilus in adherence to epithelial cells and biofilm formation in Streptococcus agalactiae. PLoS Pathog (2009) 2.15
Identification of cpsD, a gene essential for type III capsule expression in group B streptococci. Mol Microbiol (1993) 2.09
Defective cell wall synthesis in Streptococcus pneumoniae R6 depleted for the essential PcsB putative murein hydrolase or the VicR (YycF) response regulator. Mol Microbiol (2004) 2.02
Anchoring of surface proteins to the cell wall of Staphylococcus aureus. III. Lipid II is an in vivo peptidoglycan substrate for sortase-catalyzed surface protein anchoring. J Biol Chem (2002) 1.97
CovS/CovR of group B streptococcus: a two-component global regulatory system involved in virulence. Mol Microbiol (2004) 1.94
A microdomain for protein secretion in Gram-positive bacteria. Science (2004) 1.84
The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol Microbiol (1999) 1.79
The SrtA Sortase of Streptococcus agalactiae is required for cell wall anchoring of proteins containing the LPXTG motif, for adhesion to epithelial cells, and for colonization of the mouse intestine. Infect Immun (2005) 1.75
The different shapes of cocci. FEMS Microbiol Rev (2008) 1.72
Signal sequence directs localized secretion of bacterial surface proteins. Nature (2006) 1.57
Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae. Infect Immun (2001) 1.43
The ExPortal: an organelle dedicated to the biogenesis of secreted proteins in Streptococcus pyogenes. Mol Microbiol (2005) 1.41
A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J Clin Invest (2003) 1.36
Signal peptides direct surface proteins to two distinct envelope locations of Staphylococcus aureus. EMBO J (2008) 1.35
The YSIRK-G/S motif of staphylococcal protein A and its role in efficiency of signal peptide processing. J Bacteriol (2003) 1.27
Molecular dissection of the secA2 locus of group B Streptococcus reveals that glycosylation of the Srr1 LPXTG protein is required for full virulence. J Bacteriol (2009) 1.27
Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor. Med Microbiol Immunol (1994) 1.25
Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin. J Biol Chem (2003) 1.22
Anionic lipids enriched at the ExPortal of Streptococcus pyogenes. J Bacteriol (2006) 1.14
Influence of proteins Bsp and FemH on cell shape and peptidoglycan composition in group B streptococcus. Microbiology (2002) 1.00
Streptococcus agalactiae CspA is a serine protease that inactivates chemokines. J Bacteriol (2008) 0.96
Characterization of a unique glycosylated anchor endopeptidase that cleaves the LPXTG sequence motif of cell surface proteins of Gram-positive bacteria. J Biol Chem (2002) 0.96
Localization of surface immunogenic protein on group B streptococcus. Infect Immun (2001) 0.91
Cellular aspects of the distinct M protein and SfbI anchoring pathways in Streptococcus pyogenes. Mol Microbiol (2012) 0.87
CAMP factor is not essential for systemic virulence of Group B Streptococcus. Microb Pathog (2007) 0.87
Cell wall antibiotics provoke accumulation of anchored mCherry in the cross wall of Staphylococcus aureus. PLoS One (2012) 0.85
Purification and characterization of LPXTGase from Staphylococcus aureus: the amino acid composition mirrors that found in the peptidoglycan. J Bacteriol (2006) 0.81
Spatial positioning of cell wall-anchored virulence factors in Gram-positive bacteria. Curr Opin Microbiol (2012) 0.79
Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol (2002) 4.82
Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J Clin Microbiol (2004) 3.96
Assembly and role of pili in group B streptococci. Mol Microbiol (2006) 2.92
Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature (2009) 2.68
Sorting sortases: a nomenclature proposal for the various sortases of Gram-positive bacteria. Res Microbiol (2005) 2.20
Dual role for pilus in adherence to epithelial cells and biofilm formation in Streptococcus agalactiae. PLoS Pathog (2009) 2.15
Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol Microbiol (2002) 2.15
Shaping a bacterial genome by large chromosomal replacements, the evolutionary history of Streptococcus agalactiae. Proc Natl Acad Sci U S A (2008) 2.06
Taxonomic dissection of the Streptococcus bovis group by analysis of manganese-dependent superoxide dismutase gene (sodA) sequences: reclassification of 'Streptococcus infantarius subsp. coli' as Streptococcus lutetiensis sp. nov. and of Streptococcus bovis biotype 11.2 as Streptococcus pasteurianus sp. nov. Int J Syst Evol Microbiol (2002) 2.01
TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe (2008) 1.98
CovS/CovR of group B streptococcus: a two-component global regulatory system involved in virulence. Mol Microbiol (2004) 1.94
Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol (2007) 1.91
Genomic diversity and evolution within the species Streptococcus agalactiae. Microbes Infect (2006) 1.86
The SrtA Sortase of Streptococcus agalactiae is required for cell wall anchoring of proteins containing the LPXTG motif, for adhesion to epithelial cells, and for colonization of the mouse intestine. Infect Immun (2005) 1.75
Genome sequence of Streptococcus gallolyticus: insights into its adaptation to the bovine rumen and its ability to cause endocarditis. J Bacteriol (2010) 1.64
Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Mol Microbiol (2003) 1.53
The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med (2010) 1.51
Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis. J Immunol (2008) 1.40
Characterization of a serine/threonine kinase involved in virulence of Staphylococcus aureus. J Bacteriol (2009) 1.36
Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol (2005) 1.35
Rapid detection of the "highly virulent" group B Streptococcus ST-17 clone. Microbes Infect (2006) 1.31
Cell surface of Lactococcus lactis is covered by a protective polysaccharide pellicle. J Biol Chem (2010) 1.29
Molecular dissection of the secA2 locus of group B Streptococcus reveals that glycosylation of the Srr1 LPXTG protein is required for full virulence. J Bacteriol (2009) 1.27
Activation of the NLRP3 inflammasome by group B streptococci. J Immunol (2012) 1.25
Respiration metabolism of Group B Streptococcus is activated by environmental haem and quinone and contributes to virulence. Mol Microbiol (2005) 1.24
Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother (2003) 1.24
The putative glycosyltransferase-encoding gene cylJ and the group B Streptococcus (GBS)-specific gene cylK modulate hemolysin production and virulence of GBS. Infect Immun (2007) 1.22
Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein. J Immunol (2007) 1.18
Invasive group B streptococcal infections in infants, France. Emerg Infect Dis (2008) 1.18
Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes. J Cell Sci (2003) 1.18
Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. J Infect Dis (2012) 1.17
Native valve endocarditis due to Enterococcus hirae. J Clin Microbiol (2002) 1.15
Pili of gram-positive bacteria: roles in host colonization. Res Microbiol (2012) 1.14
The Listeria monocytogenes InlC protein interferes with innate immune responses by targeting the I{kappa}B kinase subunit IKK{alpha}. Proc Natl Acad Sci U S A (2010) 1.11
The Group B Streptococcus NADH oxidase Nox-2 is involved in fatty acid biosynthesis during aerobic growth and contributes to virulence. Mol Microbiol (2006) 1.07
D-alanylation of lipoteichoic acids confers resistance to cationic peptides in group B streptococcus by increasing the cell wall density. PLoS Pathog (2012) 1.05
Atypical association of DDE transposition with conjugation specifies a new family of mobile elements. Mol Microbiol (2008) 1.04
Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis. J Infect Dis (2011) 0.98
Group B streptococcus GAPDH is released upon cell lysis, associates with bacterial surface, and induces apoptosis in murine macrophages. PLoS One (2012) 0.97
An in silico model for identification of small RNAs in whole bacterial genomes: characterization of antisense RNAs in pathogenic Escherichia coli and Streptococcus agalactiae strains. Nucleic Acids Res (2011) 0.97
Rapid and accurate identification of human isolates of Pasteurella and related species by sequencing the sodA gene. J Clin Microbiol (2005) 0.96
Group B streptococcal haemolysin and pigment, a tale of twins. FEMS Microbiol Rev (2014) 0.95
The 2-Cys peroxiredoxin alkyl hydroperoxide reductase c binds heme and participates in its intracellular availability in Streptococcus agalactiae. J Biol Chem (2010) 0.95
Interaction with human plasminogen system turns on proteolytic activity in Streptococcus agalactiae and enhances its virulence in a mouse model. Microbes Infect (2007) 0.93
Role of the Group B antigen of Streptococcus agalactiae: a peptidoglycan-anchored polysaccharide involved in cell wall biogenesis. PLoS Pathog (2012) 0.91
Genetic basis of antibiotic resistance in clinical isolates of Streptococcus gallolyticus (Streptococcus bovis). Antimicrob Agents Chemother (2005) 0.90
Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis. Emerg Infect Dis (2008) 0.90
Roles of environmental heme, and menaquinone, in streptococcus agalactiae. Biometals (2006) 0.90
Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment. PLoS Pathog (2011) 0.89
Group B Streptococcus surface proteins as major determinants for meningeal tropism. Curr Opin Microbiol (2011) 0.89
Adult zebrafish model of bacterial meningitis in Streptococcus agalactiae infection. Dev Comp Immunol (2012) 0.88
The Abi-domain protein Abx1 interacts with the CovS histidine kinase to control virulence gene expression in group B Streptococcus. PLoS Pathog (2013) 0.88
Poliovirus transcytosis through M-like cells. J Gen Virol (2002) 0.88
Extracellular nucleotide catabolism by the Group B Streptococcus ectonucleotidase NudP increases bacterial survival in blood. J Biol Chem (2014) 0.87
Effect of PhoP-PhoQ activation by broad repertoire of antimicrobial peptides on bacterial resistance. J Biol Chem (2011) 0.87
Role of the Streptococcus agalactiae ClpP serine protease in heat-induced stress defence and growth arrest. Microbiology (2003) 0.86
Lymphoepithelial interactions trigger specific regulation of gene expression in the M cell-containing follicle-associated epithelium of Peyer's patches. J Immunol (2002) 0.86
The GBS PI-2a pilus is required for virulence in mice neonates. PLoS One (2011) 0.85
Epidemiologically and clinically relevant Group B Streptococcus isolates do not bind collagen but display enhanced binding to human fibrinogen. Microbes Infect (2012) 0.85
Group B Streptococcus hijacks the host plasminogen system to promote brain endothelial cell invasion. PLoS One (2013) 0.84
FbsC, a novel fibrinogen-binding protein, promotes Streptococcus agalactiae-host cell interactions. J Biol Chem (2014) 0.84
Molecular mapping of the cell wall polysaccharides of the human pathogen Streptococcus agalactiae. Nanoscale (2014) 0.84
TLR2-induced IL-10 production impairs neutrophil recruitment to infected tissues during neonatal bacterial sepsis. J Immunol (2013) 0.84
Rga, a RofA-like regulator, is the major transcriptional activator of the PI-2a pilus in Streptococcus agalactiae. Microb Drug Resist (2012) 0.83
Selective antibody response to Streptococcus gallolyticus pilus proteins in colorectal cancer patients. Cancer Prev Res (Phila) (2011) 0.82
Expression and distribution of beta1 integrins in in vitro-induced M cells: implications for Yersinia adhesion to Peyer's patch epithelium. Cell Microbiol (2004) 0.82
Comparison of the Diversilab® system with multi-locus sequence typing and pulsed-field gel electrophoresis for the characterization of Streptococcus agalactiae invasive strains. J Microbiol Methods (2011) 0.82
Analysis of the Streptococcus agalactiae exoproteome. J Proteomics (2013) 0.80
Comparative evaluation of VITEK 2 for antimicrobial susceptibility testing of group B Streptococcus. J Antimicrob Chemother (2007) 0.79
Spatial positioning of cell wall-anchored virulence factors in Gram-positive bacteria. Curr Opin Microbiol (2012) 0.79
Molecular basis for different levels of tet(M) expression in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother (2012) 0.79
Construction of isogenic mutants in Streptococcus gallolyticus based on the development of new mobilizable vectors. Res Microbiol (2013) 0.78
Genetics of streptococci, lactococci, and enterococci: review of the sixth international conference. J Bacteriol (2002) 0.78
Characterization of the calcium-binding sites of Listeria monocytogenes InlB. Biochem Biophys Res Commun (2004) 0.78
Corrigendum: Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat Commun (2015) 0.75
[Why group A streptococci is strictly pathogen in human? A first answer given by a humanized mouse model]. Med Sci (Paris) (2005) 0.75
[A breakthrough in the understanding of neonatal group B streptococcus meningitis]. Med Sci (Paris) (2011) 0.75